Land: Den Europæiske Union
Sprog: engelsk
Kilde: EMA (European Medicines Agency)
Glycopyrronium bromide, Indacaterol (acetate), Mometasone furoate
Novartis Europharm Limited
R03AL
indacaterol, glycopyrronium, mometasone furoate
Drugs for obstructive airway diseases,
Asthma
Maintenance treatment of asthma in adults whose disease is not adequately controlled.
Revision: 4
Authorised
2020-07-03
44 B. PACKAGE LEAFLET 45 PACKAGE LEAFLET: INFORMATION FOR THE USER ZIMBUS BREEZHALER 114 MICROGRAMS/46 MICROGRAMS/136 MICROGRAMS INHALATION POWDER, HARD CAPSULES indacaterol/glycopyrronium/mometasone furoate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Zimbus Breezhaler is and what it is used for 2. What you need to know before you use Zimbus Breezhaler 3. How to use Zimbus Breezhaler 4. Possible side effects 5. How to store Zimbus Breezhaler 6. Contents of the pack and other information Instructions for use of Zimbus Breezhaler inhaler 1. WHAT ZIMBUS BREEZHALER IS AND WHAT IT IS USED FOR WHAT ZIMBUS BREEZHALER IS AND HOW IT WORKS Zimbus Breezhaler contains three active substances: - indacaterol - glycopyrronium - mometasone furoate Indacaterol and glycopyrronium belong to a group of medicines called bronchodilators. They work in different ways to relax the muscles of the small airways in the lungs. This helps to open the airways and makes it easier for air to get in and out of the lungs. When they are taken regularly, they help the small airways to remain open. Mometasone furoate belongs to a group of medicines called corticosteroids (or steroids). Corticosteroids reduce the swelling and irritation (inflammation) in the small airways in the lungs and so gradually ease breathing problems. Corticosteroids also help to prevent attacks of asthma. WHAT ZIMBUS BREEZHALER IS USED FOR Zimbus Breezhaler is used regularly as treatment for asthma in adults. Asthma is a serious, long-term Læs hele dokumentet
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Zimbus Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 150 mcg of indacaterol (as acetate), 63 mcg of glycopyrronium bromide equivalent to 50 mcg of glycopyrronium and 160 mcg of mometasone furoate. Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 114 mcg of indacaterol (as acetate), 58 mcg of glycopyrronium bromide equivalent to 46 mcg of glycopyrronium and 136 mcg of mometasone furoate. Excipient(s) with known effect Each capsule contains 25 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Inhalation powder, hard capsule (inhalation powder). Capsules with green transparent cap and uncoloured transparent body containing a white powder, with the product code “IGM150-50-160” printed in black above two black bars on the body and with the product logo printed in black and surrounded by a black bar on the cap. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Zimbus Breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta 2 -agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year. 3 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The recommended dose is one capsule to be inhaled once daily. The maximum recommended dose is 114 mcg/46 mcg/136 mcg once daily. Treatment should be administered at the same time of the day each day. It can be administered irrespective of the time of the day. If a dose is missed, it should be taken as soon as possible. Patients should be instructed not to take more than one dose in a day. _Special populations _ _Elderly population_ No dose adjustment is required in elderly patients (65 years of age or older) (see section 5.2). _Renal impairment_ No dose Læs hele dokumentet